Wednesday, September 16, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesGalderma's Restylane Volyme Wins China Temple StudytodayBusiness & M&AEL.En. Profit Surges 45% on Medical Aesthetics Shift2 days agoBusiness & M&AInMode Takeover Bid Expires—Stock Pressure MountstodayMarketGLP-1 Users Driving Body Contouring Surge—Practices Adapt Service Mix2 days agoInjectablesMerz Expands Belotero With Volume and Intense FillerstodayDevices & TechBTL Launches EXOLASE ONE—Fused Erbium Laser Enters Crowded Market2 days agoDevices & TechInMode Launches Morpheus8 Cool on Morpheus8MAXtodayDevices & TechInMode Adds Cooling to Morpheus8MAX—RF Microneedling Gets Comfort Edge2 days agoInjectablesMerz Gets FDA Nod for BELOTERO VOLUME and INTENSEyesterdayBusiness & M&AEL.En. Medical Segment Drives 9% Revenue GrowthyesterdayDevices & TechECHOLASER X4 Clears FDA 510(k) for General SurgeryyesterdayBusiness & M&AGalderma's Launch Spend Paying Off as Margins Widenyesterday
Business & M&A

Steel Partners Escalates InMode Pressure Over Governance

Activist investor cites 'egregious' failures, signals potential proxy fight or bid.

Image: Inside MedSpa
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

Steel Partners Holdings has issued a letter to InMode's board citing what it characterizes as "persistent and egregious governance failures," escalating pressure on the RF and ultrasound device maker. The move signals Steel Partners—which has built a meaningful stake—is prepared to pursue board representation or a full acquisition if governance concerns are not addressed.

InMode's stock has underperformed relative to peers over the past 18 months despite strong installed base and recurring revenue from consumables (tips, handpieces). Governance critiques typically center on capital allocation, dividend policy, and strategic direction—areas where activist investors often see value unlocking potential.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Activist investor Steel Partners escalates pressure on InMode board over governance.

For practices, this matters because device consolidation often follows activist campaigns. If Steel Partners succeeds in gaining influence or acquiring InMode, integration with other portfolio companies or a sale to a larger player (Cutera, Candela, or a PE fund) could reshape pricing, support, and loyalty-program terms. Watch for proxy filings and board composition changes in coming weeks.

Source: original report ↗

Frequently asked questions

What is Steel Partners doing with InMode?

Steel Partners, an activist investor with a meaningful stake, has sent a letter to InMode's board citing 'persistent and egregious governance failures' and signaling it may pursue board representation or a full acquisition if governance concerns aren't addressed. The move escalates pressure on the RF and ultrasound device maker over capital allocation, dividend policy, and strategic direction.

Why has InMode stock underperformed?

InMode's stock has underperformed relative to peers over the past 18 months despite having a strong installed base and recurring revenue from consumables like tips and handpieces. Activist investors like Steel Partners believe governance failures around capital allocation and strategic direction are preventing the company from unlocking shareholder value.

Could InMode be acquired?

Yes. If Steel Partners gains board influence or pursues a full acquisition, InMode could be integrated into Steel Partners' portfolio companies or sold to a larger player like Cutera, Candela, or a private equity fund. Device consolidation often follows activist campaigns and can reshape the competitive landscape.

How could an InMode acquisition affect my practice?

Device consolidation under new ownership could change pricing, support quality, and loyalty-program terms for practices using InMode equipment. Practices should monitor proxy filings and board composition changes in the coming weeks to anticipate potential shifts in vendor relationships and service levels.

What should medspa owners watch for regarding InMode?

Watch for proxy filings, board composition announcements, and any statements from Steel Partners or InMode management in the coming weeks. These will signal whether Steel Partners is pursuing board seats, a full acquisition, or a negotiated settlement—each outcome could have different implications for device pricing and support.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/steel-partners-inmode-governance-letter/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Get the free brief Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Get the free brief